Anika Therapeutics Inc. · NASDAQ:ANIK

Anika Therapeutics — Q2 2015 Earnings Presentation

7 slides from Anika Therapeutics's earnings presentation, Jul 30, 2015

  1. Slide 1: Second Quarter 2015 Business Update

    ANIKA THERAPEUTICS, INC. Second Quarter 2015 Business Update July 30, 2015

  2. Slide 2: Safe Harbor Statement

    SAFE HARBOR STATEMENT The statements made in this presentation that are not statements of historical fact are forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements involve known an

  3. Slide 3: Solid Q2 2015: Progress on All Fronts

    SOLID Q2 2015: PROGRESS ON ALL FRONTS Robust Growing Steady End-User Financial Pipeline Demand Strength Progress ORTHOVISC Leads $22.9M Revenue IDE Filed/Approved Multi-Injection for MONOVISC Market $7.8M Net Income IDE Approved for MONOVISC is #2 in $0.51 Diluted EPS HYALOFAST Single-Injection Mark

  4. Slide 4: ORTHOVISC & MONOVISC: Expanding Reach

    ORTHOVISC & MONOVISC: EXPANDING REACH Gains in U.S. International New Visco Market Traction Indication New Distribution Agreements Signed 26% for MONOVISC IDE for Hip OA Pain Submitted/Approved for MONOVISC India Australia ORTHOVISC & MONOVISC Combined Share of 26% 4

  5. Slide 5: Pipeline Advancement: Setting the Future

    PIPELINE ADVANCEMENT: SETTING THE FUTURE • Poised to be First Viscosupplement to Combine HA Formulation with a Well-Established Steroid CINGAL • 13-02 Study Demonstrates Excellent Safety Profile • In Regulatory Process in U.S., Europe, and Canada • Biodegradable 3D Scaffold that Enables and Promotes

  6. Slide 6: Solid Financial Results in Q2 2015

    SOLID FINANCIAL RESULTS IN Q2 2015 Product • End-User Demand Driving Growth Revenue • Mitek Inventory Adjustment to Complete in Q3 8% of YoY growth of consecutive growth 38th Quarter for ORTHOVISC 4th Quarter for MONOVISC Excluding impact of Q2 FY14 Net Diluted $5M Milestone Payment. . . Income EPS

  7. Slide 7: Q&A

    Q&A Anika Therapeutics, Inc. Second Quarter 2015 Business Update July 30, 2015

Anika Therapeutics — Q2 2015 Earnings Presentation on 6ix